The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.

 
Web www.patentalert.com

< si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation

> Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives

> HOMEOPATHIC COMPOSITION AND KIT THEREFORE

~ 00521